Acrospire Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,876
Closed -$11K 1554
2017
Q2
$11K Sell
1,876
-7,793
-81% -$45.7K 0.01% 1779
2017
Q1
$42K Sell
9,669
-831
-8% -$3.61K 0.03% 1106
2016
Q4
$18K Buy
10,500
+7,900
+304% +$13.5K 0.01% 1796
2016
Q3
$5K Sell
2,600
-300
-10% -$577 ﹤0.01% 1833
2016
Q2
$5K Buy
+2,900
New +$5K ﹤0.01% 1869